becton dickinson co
steadi execut takeaway
even exclud flu stand-alon rev better expect initi
pro-forma guidanc incorpor bcr mostli expect lsd
accret still seem conserv sever front rais
ep forecast respect
strong fundament room upsid like stock con view
rel safe choppi tape maintain buy pt
thesi see compel defens larg cap hold given abil drive
durabl core growth mid-teen ep growth thru still support
dividend success integr bcr key stock
stand-alon good start think core revenue growth vs
toward high-end expect flu impact
account one-third beat ex pyxi account chang tough comp
favor order time underli core growth
balanc growth life core drove upsid partli aid
flu strength across ex-flu bioscienc
medic ex-pyxi better mostli driven pharm system
develop mkt ex-pyxi stabl emerg mkt grew china
major surpris pf guid bcr lot move part
revis outlook still feel conserv flu tax fx bcr accret
expect lsd tax fx tailwind overal ep move
account bcr accret net timing/divestitur fx
 tax off-set revenu synergi invest higher resin off-set
flu benefit top line re-affirmed core stand-alon outlook ex-
pyxi point core-bcr growth ex-hurrican impact yield pf
newco core growth vs pf basi fx vs
factor euro average
ep power approach revis ep factor
bcr accret hsd core growth faster synergi captur debt
paydown fx could push closer
pt reflect horizon dcf impli ev ebitda/
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
nopat compound-annual-growth-rate next decad
realiz cfn-relat cost synergi
realiz bcr-relat cost synergi
yr
price multipl ep ev
organ revenu growth new product
see compel defens larg cap
hold given abil drive durabl core
growth mid-teen ep growth thru still
support dividend success integr bcr
paramount stock
realiz bcr-relat cost synergi
organ revenu growth new product
minim cfn bcr-relat revenu synergi
page
pleas see import disclosur inform page report
